According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -1,28ย โฌ. In 2015 the company made an earnings per share (EPS) of -5,78ย โฌ an increase over its 2014 EPS that were of -8,74ย โฌ.